Astex Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

ASTX 0.0000
price chart
Pomerantz Announces Notice of Dismissal of Astex Pharmaceuticals, Inc. Class ...
NEW YORK, Nov. 11, 2014 (GLOBE NEWSWIRE) -- By order of the Delaware Court of Chancery dated November 5, 2014, the following notice is being published.
Related articles »  
James Manuso, chairman and CEO of Astex Pharmaceuticals Inc.
Background: Manuso, a self-described “Euro mutt,” joined SuperGen Inc. as a director in 2001 and became chairman and CEO of Astex Pharma after SuperGen's acquisition last summer of Astex Therapeutics Ltd. in the U.K. The 140-employee company has ...
Japan's Otsuka to buy US cancer firm Astex for $886 million
TOKYO Japanese drugmaker Otsuka Holdings Co has agreed to buy Astex Pharmaceuticals Inc for about $886 million to tap cancer drugs under development by the U.S.
Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals  EON: Enhanced Online News (press release)
Otsuka Emerges as Highest Bidder; Snags Astex for $886M  BioWorld Online
Related articles »  
Astex Pharmaceuticals Announces Publication of Key Clinical Data for ...
BUSINESS WIRE)--Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announces the publication of key clinical data for the novel hypomethylating agent (HMA) ...
SuperGen, Inc. Changes Name To Astex Pharmaceuticals, Inc., Announces New ...
SuperGen, Inc. (NASDAQ:ASTX) announced that it has officially begun operating under the name Astex Pharmaceuticals, Inc. Concurrent with this new name, and effective at the start of trading today, September 12, 2011, the ticker symbol for the Company's ...
SuperGen changes name to Astex Pharma after deal  BusinessWeek
Astex Pharma shareholder opposes $886 million bid by Otsuka
Otsuka Holdings Co's (4578.T) $886 million bid for Astex Pharmaceuticals Inc ASTX.O has run into opposition from an activist shareholder who says the deal significantly undervalues the U.S.
Related articles »  
5 Reasons To Buy Astex Pharmaceuticals
Astex Pharmaceuticals has established a broad pipeline of small molecule, molecularly-targeted drugs using its drug discovery engine, Pyramid, which is also used to support the company's drug discovery collaborations with leading pharmaceutical company ...
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in ...
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced today its plan to submit an ...
Related articles »  
Astex Pharmaceuticals Presents Final Results of Phase 2 Study of SGI-110 in ...
DUBLIN, Calif. & CAMBRIDGE, England--(BUSINESS WIRE)--Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, presented the final results of a Phase 2 study of SGI-110, ...
Related articles »  
Astex Pharmaceuticals: Heading For New Highs On Strong Pipeline Momentum
We believe that Astex Pharmaceuticals' (NASDAQ:ASTX) shares represent an excellent buying opportunity. Despite positive recent developments at Astex, the company has seemingly gotten lost in the shuffle, with shares slumping sharply - more than 35 ...
Related articles »